Computime Announces FY24/25 Interim Results
Financial Results Met Our Expectations Amid Macroeconomic Challenges and Climatic Factors Strengthening Global Presence Through "Glocalization" Approach HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Computime Group Limited (the "Company" or "Computime",...
Körber Delivers Advanced Warehouse Automation Solution for Iron Mountain
SINGAPORE, Nov. 28, 2024 /PRNewswire/ -- Körber is proud to announce a new collaboration with Iron Mountain, a global leader in information management services. This exciting new project further expands Körber's footprint in Southeast Asia and...
Don't Miss Out - Time's Running Out to Get Up to 60% Off in COSRX's Black Friday/Cyber Monday Sale!
Viral K-Beauty Favorites on Sale and Available on Amazon! NEW YORK, Nov. 28, 2024 /PRNewswire/ -- Viral K-Beauty brand, COSRX announces unbeatable Black Friday & Cyber Monday (BFCM) deals on must-have skincare duos! During this highly...
New Canadian Distributor UNIVELO Announces Exclusive Distribution of AIMA E-Bikes in Canada
QUEBEC CITY, QC, Nov. 28, 2024 /PRNewswire/ -- UNIVELO, a newly established Canadian distribution company, is excited to announce its partnership with AIMA Technology Group, a leading innovator in the electric vehicle industry, known for designing...
Gravity Announces Global Release of Tokyo Psychodemic
Available now on PlayStation®4, PlayStation®5, and Nintendo Switch™, with updated language support on Steam®. Digital versions are available for immediate download and play through the PlayStation Store and Nintendo eShop. SEOUL, South Korea, Nov....
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List
SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country
SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing...
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Appian Announces 2024 APJ Partner Award Winners
Recognising WNS-Vuram, Deloitte, Cognizant, KPMG, Accenture, and Via Appia for delivering process excellence SYDNEY, Nov. 28, 2024 /PRNewswire/ -- Appian (Nasdaq: APPN) today unveiled the recipients of its 2024 Asia-Pacific and Japan (APJ) Partner...
Education Cannot Wait Launches US$1.9 Million Groundbreaking Grants to Advance Gender Equality in Education in Emergencies and Protracted Crises
NEW YORK, Nov. 28, 2024 /PRNewswire/ -- Education Cannot Wait (ECW), the global fund for education in emergencies and protracted crises in the United Nations, announces two new grants, totalling $1.9 million. The grants will be delivered in...